Latest Financials News

GQG Partners Inc. has announced a quarterly ordinary dividend of USD 0.0378 per CDI, payable on March 27, 2025, with an option for Australian dollar conversion at a specified exchange rate.

GQG Partners Inc. reported strong financial results for 2024, with significant increases in revenue, net income, and funds under management, alongside a raised dividend and strategic moves including the deconsolidation of its PCS Master Fund.

AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.

AVITA Medical reported a robust 30% increase in Q4 2024 commercial revenue alongside key FDA clearances, setting the stage for ambitious growth in 2025.

Olympio Metals has entered an Option Agreement to sell its remaining Halls Creek tenements to Clutch Group, enabling a sharper focus on its flagship Dufay Cu-Au Project in Quebec.

Civmec’s 1H FY25 results reveal robust revenue growth and a strong balance sheet, underpinned by a diversified project pipeline and strategic moves into naval shipbuilding and material handling equipment manufacturing.

Civmec Limited reports solid first-half FY25 results with revenue growth and a stable dividend, while navigating margin pressures and advancing strategic projects.

Sipa Resources has completed the acquisition of four advanced gold exploration projects across South Australia and Western Australia, backed by a $1.75 million capital raise and the strategic appointment of industry veteran Stephen Biggins to its board.

Cochlear Limited posted a 6% increase in HY25 sales revenue driven by strong implant sales but anticipates FY25 profits at the lower end of guidance due to declining services revenue and rising cloud investments.

HealthCo Healthcare & Wellness REIT reported a solid 5% increase in Funds From Operations (FFO) and Distribution Per Unit (DPU) for the first half of FY25, underpinned by stable asset valuations and a robust healthcare portfolio.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

Cochlear Limited has announced a fully franked dividend of AUD 2.15 per share for the six months ending December 2024, payable in multiple currencies on April 14, 2025.